At the crowded MedtechPartners meeting on 7 March André van de Sande was presented by programme director Joep Welschen to the partners as the new chairman of the board of MedtechPartners.
On Monday 4 March 2019, NWO has launched the second funding round of the NWA research programme 'Research along Routes by Consortia' (ORC). The funding programme aimed at all research disciplines stimulates interdisciplinary research and innovation, bringing societal and scientific breakthroughs within reach. For the 2019 funding round a budget of 80.5 million euros is available.
EMA has published a booklet describing the journey of a medicine for human use authorised through EMA, from initial research to discussions on patient access to medicines across the EU:
Scientists from the Hubrecht Institute, the University of Utrecht, and MIMETAS have successfully grown kidney tubules derived from human kidney adult stem cells in microfluidic chips. This research has been published in Nature Biotechnology by the world-leading research group from Professor Hans Clevers.
32 leading scientists will each receive 1.5 million euros from the Netherlands Organisation for Scientific Research (NWO). This Vici grant will enable them to develop an innovative line of research and set up their own research group in the coming five years.
A new training & mentoring programme to accelerator the development of the next generation BioBusiness Leaders in Life Sciences & Health is launched this year by HELIS Academy. This programme, named TAP BioBusiness is an intensive 8-month programme.
Hubrecht Organoid Technology (HUB) and Yamaha Motor have announced their collaboration to provide solutions that deepen our understanding in predictive diagnostic of patients.
Succesvol ondernemerschap beloont zichzelf. Maar wie beloont degenen die met creatieve en inspirerende initiatieven ondernemerschap stimuleren? Met de Europese Awards voor Ondernemerschapsbevordering (EEPA) erkent en beloont de Europese Commissie successen van openbare instanties en publiek-private samenwerkingsverbanden. Het doel is ondernemerschap te bevorderen.
Sapreme Technologies, a privately-held biotech company developing a technology platform to enable the cytosolic delivery of macromolecule therapeutics, has been awarded a 6.8 M€ grant together with a multidisciplinary consortium including 11 other academic and industrial parties.
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announced that DSM Venturing, its venture investment arm, has made an equity investment in skin microbiome company S-Biomedic NV. This investment completes S-Biomedic’s latest Series A financing round.